Generate a tailored SOP for Dr. Maureen Murphy. Improve your application with a focused, well-structured draft.
Dr. Maureen E. Murphy is a prominent researcher focusing on tumor suppressor proteins, particularly those commonly mutated in human cancers, such as p53 and p14ARF. Her laboratory studies the regulatory roles of these proteins in apoptosis and autophagy, essential mechanisms in cellular responses to cancer. Dr. Murphy’s research on apoptosis emphasizes the genetic polymorphisms in the p53 tumor suppressor gene, particularly in African American populations, which may influence individual cancer risk and therapeutic outcomes. Additionally, she explores the targeting of the autophagy pathway as a potential therapeutic strategy in cancer, utilizing small molecule inhibitors such as Heat Shock Protein 70 (HSP70) to selectively kill tumor cells. Dr. Murphy's work is vital in enhancing the understanding of cancer biology, particularly how inter-individual genetic variations affect cancer susceptibility and treatment efficacy.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.